You are here

Stem Cell Therapeutics for Frailty

A new STEM CELLS Translational Medicine article from José Becerra and Ivan Duran (University of Málaga, IBIMA, Málaga, Spain) summarizes our current understanding of frailty from processes mediated by inflammation, aging, and stem cells to provide a new perspective that unifies efforts in producing advanced therapies against frailty-related medical conditions. The authors believe these approaches possess particular relevance to COVID-19, as frail patients die more frequently due to the associated hyperinflammatory process.